Home › Law Database › Switzerland

Are peptides legal in Switzerland?

Sourced guide to the legal status of peptides in Switzerland, refreshed automatically from live research.

Overall Status: Restricted

Short answer: Peptides such as BPC-157, TB-500, semaglutide-class drugs, and HGH are not freely legal in Switzerland for human use; they are treated as medicinal products under the Therapeutic Products Act and can only be lawfully sold, prescribed, or imported for personal medical use if authorized by Swissmedic, with unapproved 'research peptides' falling into a legal gray/restricted zone when sold or imported for human consumption.

Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.

Overview

Peptides are restricted in Switzerland: any substance intended to produce a pharmacological, immunological, or metabolic effect in humans is legally classified as a medicinal product (Arzneimittel) under the Swiss Therapeutic Products Act (Heilmittelgesetz, HMG), and Swissmedic is the national authority that must authorize a product before it can be marketed or supplied. Approved peptide-class drugs (e.g., semaglutide/tirzepatide for diabetes or obesity, and somatropin/HGH) are legal only as prescription-only medicines dispensed through licensed pharmacies. Unapproved 'research chemical' peptides like BPC-157 and TB-500 have no Swissmedic marketing authorization for human use, so manufacturing, advertising, selling, or importing them for human consumption is not permitted under the HMG framework, even though the underlying peptide molecules are not separately named as narcotics under Swiss drug law.

Key Points

  • Switzerland classifies any substance intended to exert a pharmacological, immunological, or metabolic effect on the human body as a 'medicinal product' (Arzneimittel) under the Therapeutic Products Act, meaning peptides marketed for human use fall under Swissmedic's authorization requirements rather than existing in an unregulated category. [1]
  • Swissmedic requires marketing authorization before any medicinal product, including peptide-based drugs, can be legally sold or advertised in Switzerland, and selling unauthorized medicinal products is a criminal offense under the Heilmittelgesetz. [1]
  • Swissmedic-authorized peptide drugs such as semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) are dispensed only as prescription-only medicines through licensed pharmacies in Switzerland. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
  • Human growth hormone (somatropin) is a Swissmedic-authorized prescription-only medicine in Switzerland and is also a substance prohibited in competitive sport under Swiss anti-doping rules, so its non-medical or unauthorized supply carries additional scrutiny. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
  • Personal importation of medicines into Switzerland is generally permitted only in small quantities for an individual's own therapeutic use and typically requires the product to be a legitimately authorized or prescribed medicine, not an unapproved research-grade peptide; unauthorized research peptides brought in for human use risk seizure by Swiss customs and Swissmedic enforcement. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
  • Unapproved 'research chemical' peptides like BPC-157 and TB-500 have no Swissmedic marketing authorization for human use in Switzerland, so vendors selling them as human-use products (rather than clearly labeled non-human laboratory reagents) are operating outside the Heilmittelgesetz framework. [1]
  • Violations of the Therapeutic Products Act in Switzerland, including illegal manufacture, import, or sale of unauthorized medicinal products, can be prosecuted as criminal offenses carrying fines or imprisonment, rather than being treated as a purely civil or administrative matter. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)

Peptide-by-peptide status in Switzerland

BPC-157BPC-157 has no Swissmedic marketing authorization for human use in Switzerland, so it is legally an unapproved substance that cannot be lawfully sold, advertised, or prescribed as a medicine, placing it in a restricted/unauthorized 'research chemical' category rather than a legal consumer product. [1]
Semaglutide / Tirzepatide (GLP-1 class)Semaglutide and tirzepatide are legal in Switzerland only as Swissmedic-authorized, prescription-only medicines (marketed as Ozempic, Wegovy, and Mounjaro) for approved indications such as type 2 diabetes and, for some brands, chronic weight management.
TB-500TB-500 has no Swissmedic marketing authorization for human use in Switzerland, placing it in the same unauthorized 'research chemical' status as BPC-157, meaning its sale or supply for human consumption falls outside the legal medicinal-product framework. [1]
HGH (somatropin)Human growth hormone (somatropin) is legal in Switzerland only as a Swissmedic-authorized, prescription-only medicine for specific approved medical indications, and its use outside a valid prescription (including for bodybuilding or anti-aging purposes) is not a lawfully sanctioned use.

Sources

  • Swissmedic - Swiss Agency for Therapeutic Products (official site) — Switzerland's Therapeutic Products Act defines medicinal products broadly (any substance with a pharmacological/immunological/metabolic effect intended for human use) and requires Swissmedic authorization before sale, making unauthorized sale a criminal offense. (retrieved 2026-09-10)

Last researched: 2026-09-10

Frequently asked questions

Can I buy peptides like BPC-157 in Switzerland without a prescription?
No — in Switzerland, unapproved peptides such as BPC-157 have no Swissmedic marketing authorization for human use, so they cannot be lawfully sold as a human-use product with or without a prescription; only Swissmedic-authorized peptide drugs can be dispensed, and only against a valid prescription. [1]
Can I legally bring peptides into Switzerland for personal use?
Personal import into Switzerland is realistically limited to small quantities of legitimately authorized or prescribed medicines for the importer's own therapeutic use; bringing in unapproved research-grade peptides for personal human use is not a clearly sanctioned pathway and risks confiscation by customs and Swissmedic.
Can a doctor in Switzerland prescribe semaglutide or tirzepatide for weight loss via telehealth?
A Swiss-licensed physician can prescribe Swissmedic-authorized GLP-1 medicines such as semaglutide or tirzepatide for their approved indications, but the prescription must come through a legitimate medical consultation (including recognized telehealth channels operating under Swiss medical practice rules), not from an unlicensed online seller of unapproved peptides.
What happens if someone is caught selling unapproved research peptides in Switzerland?
Selling unauthorized medicinal products, including unapproved research peptides marketed for human use, is a criminal offense under Switzerland's Therapeutic Products Act and can be prosecuted with fines or imprisonment, since the law does not carve out an unregulated category for substances with pharmacological effects on humans. [1]
Is HGH (human growth hormone) legal to use in Switzerland?
HGH (somatropin) is legal in Switzerland only when used under a valid prescription for an approved medical condition through a Swissmedic-authorized product; using it without a prescription, such as for bodybuilding, falls outside the lawful medicinal-product framework and can also trigger anti-doping sanctions for competitive athletes.